Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsIndependent Health step therapy Coverage Update | …
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentIndependent HealthPolicy N/A

    Step therapy criteria for formulary medications

    Customize your policy alerts

    Sign up for all Independent Health policy alerts

    Know when Independent Health releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines step therapy (ST) requirements for medications on Independent Health 2026 formularies and explains when prior authorization is required based on prescription history; affects prescribers, pharmacies, and members covered by Independent Health formularies.

    Policy Summary
    PayerIndependent Health
    PolicyStep therapy criteria for formulary medications
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJun 1, 2026
    Last ReviewJun 1, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization when the member's Independent Health pharmacy history does not document the specified comparator drug fill within the product-specific lookback window.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    MultipleFormularies covered
    20+Products listed
    90–365dCommon lookback windows
    PA when unmetPA consequence

    Coverage Criteria by Product

    Aczone (dapsone 7.5%)

    Aczone (dapsone gel 7.5%)

    Aczone criteria: Prescription routes online if pharmacy history documents a generic 5% dapsone fill within the previous 90 days; otherwise prior authorization required.90 days

    applies to dapsone gel 7.5% external

    Antidiabetic GLP-1 medications

    GLP-1 antidiabetic products

    GLP-1 criteria: Prescription routes online if pharmacy history documents the patient has type 2 diabetes or has tried any oral antidiabetic drug (excluding metformin) within the past 130 days; otherwise prior authorization required.130 days

    applies to listed GLP-1 agents (e.g., Ozempic, Rybelsus, Trulicity, Mounjaro)

    Aprepitant (EMEND) requirements

    Coding and Lookback Windows

    Products AffectedNDC|description
    oxcarbazepine er tablet 150 mgoxcarbazepine er tablet extended release 24 hour 150 mg oral
    oxcarbazepine er tablet 300 mgoxcarbazepine er tablet extended release 24 hour 300 mg
    Products AffectedNDC|description
    QELBREE 100 mgQELBREE CAPSULE EXTENDED RELEASE 24 HOUR 100 MG ORAL
    QELBREE 150 mgQELBREE CAPSULE EXTENDED RELEASE 24 HOUR 150 MG
    QELBREE 200 mgQELBREE CAPSULE EXTENDED RELEASE 24 HOUR 200 MG ORAL
    Products AffectedNDC|description
    QUILLICHEW ER 20 mgQUILLICHEW ER TABLET CHEWABLE EXTENDED RELEASE 20 MG ORAL
    QUILLICHEW ER 30 mgQUILLICHEW ER TABLET CHEWABLE EXTENDED RELEASE 30 MG ORAL
    QUILLICHEW ER 40 mgQUILLICHEW ER TABLET CHEWABLE EXTENDED RELEASE 40 MG ORAL
    QUILLIVANT XR 25 mg/5 mLQUILLIVANT XR SUSPENSION RECONSTITUTED ER 25 MG/5ML ORAL
    Products AffectedNDC|description
    aliskiren 150 mgaliskiren fumarate tablet 150 mg oral
    aliskiren 300 mgaliskiren fumarate tablet 300 mg oral
    Products AffectedNDC|description
    SANCUSO 3.1 mg/24 hrSANCUSO PATCH 3.1 MG/24HR TRANSDERMAL
    Products AffectedNDC|description
    Serevent Diskus 50 mcgSEREVENT DISKUS AEROSOL POWDER BREATH ACTIVATED 50 MCG/ACT INHALATION
    Products AffectedNDC|description
    tazarotene cream 0.05%tazarotene cream 0.05 % external
    tazarotene cream 0.1%tazarotene cream 0.1 % external
    tazarotene gel 0.05%tazarotene gel 0.05 % external
    tazarotene gel 0.1%tazarotene gel 0.1 % external

    Provider Actions, Prior Authorization & Routing

    Prior Authorization

    Trintellix prior authorization requirement

    Claims for TRINTELLIX (vortioxetine) tablets are routed to prior authorization when the pharmacy profile does not document a recent fill of a generic SSRI (e.g., sertraline, fluoxetine, escitalopram) within the previous 90 days. Prior authorization will be required if the lookback criterion is not met.

    • Product: TRINTELLIX TABLET 5 MG ORAL
    • Lookback: generic SSRI fill within previous 90 days
    • Action: Routed to prior authorization when no qualifying SSRI fill found
    Documentation Required

    Pharmacy profile / prior-fill documentation

    Pharmacy profile / fill-history documentation is used as the trigger for routing and step edits. The dispensing pharmacy profile must show the required comparator product filled within the specified lookback window for online adjudication to pass. If the pharmacy profile is incomplete or lacks the required prior fill, the claim will route to prior authorization. Providers may submit external documentation of prior fills when the profile does not reflect them.

    Initial Therapy / Step Requirements

    Opioid initiation requirement — high‑potency opioid initiation restrictions

    High-potency opioid initiation

    Prior opioid exposure required: Pharmacy history documents narcotic medication fills within the previous 120 days before online processing of listed high-potency extended-release opioid products; absence requires prior authorization due to risks of initiating in narcotic‑naive patients.120 days

    applies to listed high‑potency ER opioids

    Trintellix initial therapy

    Trintellix prior therapy routing

    Trintellix initial: Online routing if a generic SSRI fill is documented in Independent Health prescription history within the previous 90 days; otherwise prior authorization required.90 days

    Step Therapy Tables

    RequirementLookback windowIf not met
    Trial of a specified lower-cost or alternative medication (examples include generic ondansetron for Sancuso, generic zolpidem for Belsomra, alendronate for Binosto, generic NSAID for diclofenac potassium) as indicated per product-specific criteria
    Product-specific (examples shown below range from 30 to 365 days depending on product)
    Prior authorization required when the patient's Independent Health pharmacy profile does not document the required comparator fill within the stated lookback window
    Product / Comparator requiredRequired lookback windowConsequence if comparator not documented
    Diclofenac potassium (migraine) — documented generic NSAID (e.g., naproxen, ibuprofen, celecoxib)
    180 days
    Prior authorization required
    RequirementLookback windowConsequence if not met
    Documentation of a prior fill of a generic methylphenidate slow‑ or extended‑release product
    120 days
    Prior authorization required if no documented prior fill within 120 days
    RequirementLookback windowConsequence if not met
    Documentation of a prior fill of immediate‑release tramadol
    90 days
    Prior authorization required if no documented immediate‑release tramadol fill within 90 days
    RequirementLookback windowConsequence if not met
    Documentation of a prior fill of a generic SSRI antidepressant (e.g., sertraline, fluoxetine, escitalopram)
    90 days
    Prescription routes online if documented; otherwise prior authorization required
    ConditionLookback windowAction
    No documented generic SSRI fill in Independent Health prescription history
    90 days
    Prior authorization required
    ConditionLookback windowAction
    No documented allopurinol fill in Independent Health prescription history
    90 days
    Prior authorization required

    Background and Definitions

    Step therapy is a utilization management tool that requires a trial of specified medications (commonly generic or lower‑cost alternatives) or documentation of a relevant diagnosis or concurrent therapy before covering a requested agent. Under this policy, many listed products will route online only when the patient's Independent Health pharmacy history documents the required comparator fill within a defined lookback window; otherwise the prescription is subject to prior authorization.

    inv-111: Step therapy (definition)
    DefinitionStep therapy: a utilization management tool requiring trial of specified medications (often generics or lower-cost alternatives) before covering a requested medication
    Formulary noteMedications requiring Step Therapy are indicated with 'ST' in the Notes column of the formulary
    PurposeHelps ensure effective, lower-cost alternatives are tried first; may also require combination therapy when appropriate
    inv-112: narcotic nave (definition)
    Definition
    Policy Summary
    PayerIndependent Health
    PolicyStep therapy criteria for formulary medications
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateJun 1, 2026
    Last ReviewJun 1, 2026
    Next Review DateN/A
    Key ActionObtain prior authorization when the member's Independent Health pharmacy history does not document the specified comparator drug fill within the product-specific lookback window.
    SourceLink
    On This Page
    Coverage Criteria by ProductCoding and Lookback WindowsProvider Actions, Prior Authorization & RoutingInitial Therapy / Step RequirementsStep Therapy TablesBackground and Definitions

    Aprepitant products

    Aprepitant criteria: Prescription routes online if pharmacy history documents a generic ondansetron fill within the previous 180 days; otherwise prior authorization required.180 days

    applies to aprepitant products (e.g., Emend)

    Belsomra

    Belsomra (suvorexant) products

    Belsomra criteria: Prescription routes online if pharmacy history documents a generic zolpidem fill within the previous 365 days; otherwise prior authorization required.365 days

    applies to Belsomra tablets

    Binosto

    Binosto (effervescent alendronate)

    Binosto criteria: Prescription routes online if pharmacy history documents an alendronate fill within the previous 90 days; otherwise prior authorization required.90 days

    applies to Binosto 70 mg effervescent

    Bromfenac ophthalmic

    Bromfenac ophthalmic solution

    Bromfenac criteria: Prescription routes online if pharmacy history documents generic bromfenac ophthalmic solution 0.09% once daily filled within the previous 90 days; otherwise prior authorization required.90 days

    applies to bromfenac 0.07% solution

    Carac

    Carac (fluorouracil topical)

    Carac criteria: Prescription routes online if pharmacy history documents fluorouracil topical filled within the previous 90 days; otherwise prior authorization required.90 days

    applies to Carac

    Entacapone / ONGENTYS

    Entacapone / ONGENTYS

    Entacapone criteria: Prescription routes online if pharmacy history documents concurrent use of a levodopa/carbidopa product; otherwise prior authorization required.concurrent use

    applies to entacapone and ONGENTYS

    Diclofenac (migraine)

    Diclofenac potassium (migraine)

    Diclofenac migraine criteria: Prescription routes online if pharmacy history documents a generic NSAID (e.g., naproxen, ibuprofen, celecoxib) filled within the previous 180 days; otherwise prior authorization required.180 days

    applies to diclofenac potassium 50 mg packets

    Point-of-sale coverage condition

    Covered at point-of-sale when ALL of the following are met for the specific product:

    Lookback fill present: The patient's Independent Health pharmacy profile documents a fill of the specified comparator medication within the stated lookback period (product-specific).product-specific (30, 90, 120, 180, or 365 days)

    If this condition is not met the claim routes to prior authorization.

    Clotrimazole/Fluconazole/Nystatin routing

    Covered/routed online when the following is documented in pharmacy history

    Clotrimazole troche/fluconazole/nystatin pathway: Patient's Independent Health prescription history documents that clotrimazole troches, fluconazole, or nystatin oral suspension was filled within the previous 30 days30 days

    If met, prescription routes online; if not met, prior authorization required

    Oxcarbazepine routing

    Covered/routed online when prior fill documented

    Oxcarbazepine: Independent Health prescription history documents oxcarbazepine was filled within the previous 90 days90 days

    If met, prescription routes online; otherwise prior authorization required

    Methylphenidate ER routing

    Covered/routed online when prior fill documented

    Methylphenidate ER products: Pharmacy history documents a generic methylphenidate slow-release or extended-release product was filled within the previous 120 days120 days

    If met, prescription routes online; otherwise prior authorization required

    Aliskiren routing

    Covered/routed online when prior fills documented

    Aliskiren: Pharmacy history documents that an ACE inhibitor and an ARB were filled within the previous 180 days180 days

    If both fills present, prescription routes online; otherwise prior authorization required

    Sancuso routing

    Covered/routed online when prior fill documented

    Sancuso: Pharmacy history documents ondansetron was filled within the previous 180 days180 days

    If met, prescription routes online; otherwise prior authorization required

    Serevent routing

    Covered/routed online when concurrent therapy documented

    Serevent Diskus: Pharmacy profile documents concurrent use of an inhaled corticosteroid or Spiriva (tiotropium)concurrent use

    If present, prescription routes online; otherwise prior authorization required

    Tazarotene routing

    Covered/routed online when prior topical retinoid fill documented

    Tazarotene cream/gel: Pharmacy history documents tretinoin or adapalene was filled within the previous 90 days90 days

    If met, prescription routes online; otherwise prior authorization required

    Tramadol ER routing

    Covered/routed online when prior immediate-release tramadol fill documented

    Tramadol ER: Pharmacy history documents immediate-release tramadol was filled within the previous 90 days90 days

    If met, prescription routes online; otherwise prior authorization required

    Trintellix routing

    Covered/routed online when prior SSRI fill documented

    Trintellix: Pharmacy history documents a generic SSRI antidepressant was filled within the previous 90 days; otherwise prior authorization required.90 days

    applies to Trintellix (vortioxetine)

    Febuxostat (Uloric) routing

    Covered/routed online when prior allopurinol fill documented

    Febuxostat: Pharmacy history documents allopurinol was filled within the previous 90 days; otherwise prior authorization required.90 days

    applies to febuxostat (Uloric)

    Initial routing / step-therapy conditions

    Covered when the following routing/history conditions are met (product-specific):

    Trintellix: Route online (no PA) if Independent Health prescription history documents a generic SSRI fill (e.g., sertraline, fluoxetine, escitalopram) within the previous 90 days; otherwise PA required.90 days

    supports chunk 54

    Febuxostat (Uloric): Route online if prescription history documents allopurinol filled within the previous 90 days; otherwise PA required.90 days

    supports chunk 55

    Xphozah (tenapanor): Route online if prescription history documents concurrent use of a phosphate binder within the previous 120 days; otherwise prescriber must request PA via standard authorization process.120 days

    supports chunk 57

    Zolpidem sublingual: Route online if prescription history documents generic zolpidem filled within the previous 90 days; otherwise PA required.90 days

    supports chunk 59

    Starting listed high‑potency extended‑release opioid products in a patient who is narcotic‑naive (defined by no documented narcotic fills in the prior 120 days) is not permitted to process at point‑of‑sale. These agents pose serious risks when initiated without recent opioid exposure; therefore the claim will only route online for processing if the patient's Independent Health prescription history documents narcotic medication fills within the previous 120 days. If that documentation is absent, prior authorization is required.

    The policy does not list separate clinical exclusions beyond the absence of the specified prior fills or concurrent therapies that trigger prior authorization. For products that require documented concurrent use (for example, an inhaled corticosteroid or tiotropium for certain inhaled products), if the pharmacy profile does not show the required therapy, the claim is routed to prior authorization per the stated criteria.

    No additional explicit exclusions are specified in these sections. When a required prior therapy or concurrent‑use condition (for example, documented phosphate binder use for XPHOZAH within the prior 120 days) is not evident in the Independent Health prescription history, the prescriber may submit a request for prior authorization through the standard authorization process.

    Products AffectedNDC|description
    tramadol hcl er 100 mgtramadol hcl er tablet extended release 24 hour 100 mg oral
    tramadol hcl er 200 mgtramadol hcl er tablet extended release 24 hour 200 mg
    tramadol hcl er 300 mgtramadol hcl er tablet extended release 24 hour 300 mg oral
    Products AffectedNDC|description
    TRINTELLIX 5 mgTRINTELLIX TABLET 5 MG ORAL
    TRINTELLIX 10 mgTRINTELLIX TABLET 10 MG ORAL
    TRINTELLIX 20 mgTRINTELLIX TABLET 20 MG ORAL
    Products Affected (Uloric)NDC|description
    febuxostat 40 mgfebuxostat tablet 40 mg oral
    febuxostat 80 mgfebuxostat tablet 80 mg oral
    Products listedmixed
    TRINTELLIX TABLET 5 MG ORALProduct listed in criteria block
    Products listedmixed
    febuxostat tablet 40 mg oralUloric product affected
    febuxostat tablet 80 mg oralUloric product affected
    Products listedmixed
    XPHOZAH TABLET 20 MG ORALProduct affected
    XPHOZAH TABLET 30 MG ORALProduct affected
    Products listedmixed
    zolpidem tartrate tablet sublingual 1.75 mg sublingualProduct listed
    zolpidem tartrate tablet sublingual 3.5 mg sublingualProduct listed
    inv-39: Oral antidiabetic trial lookback — within the past 130 days
    Lookback windowAny oral antidiabetic (excluding metformin) trial documented within the past 130 days
    PurposeRoutes GLP-1 antidiabetic prescriptions online when criterion met; otherwise prior authorization required
    Applies toListed GLP-1 products (e.g., Ozempic, Rybelsus, Trulicity, Mounjaro, liraglutide)
    inv-40: 90-day lookback
    Lookback window90 days (prior fill documented within the previous 90 days)
    Common useUsed for prior-fill requirements for products such as dapsone 5% (Aczone comparator), alendronate (Binosto), bromfenac ophthalmic, and fluorouracil topical (Carac)
    Consequence if not metClaim routes to prior authorization
    inv-41: 180-day lookback
    Lookback window180 days (prior fill documented within the previous 180 days)
    Common useUsed for NSAID comparator fills and for ondansetron comparators for some antiemetic products
    Consequence if not metClaim routes to prior authorization
    inv-42: 365-day lookback
    Lookback window365 days (prior fill documented within the previous 365 days)
    Common useUsed for products requiring a topical immunomodulator or zolpidem comparator within the prior year
    Consequence if not metClaim routes to prior authorization
    inv-43: NSAID lookback — 180 days
    Lookback window180 days (generic NSAID fill documented within previous 180 days)
    Applies toDiclofenac potassium (migraine) packets and other NSAID-related products as listed
    Consequence if not metClaim routes to prior authorization
    inv-44: topical immunomodulator lookback — 365 days
    Lookback window365 days (tacrolimus, pimecrolimus, or topical corticosteroid fill documented within previous 365 days)
    Applies toTopical immunomodulator routing (e.g., EUCRISA-related criteria)
    Consequence if not metClaim routes to prior authorization
    inv-45: standard medication lookback — 90 days
    Lookback window90 days (prior fill documented within the previous 90 days)
    Applies toStandard prior-fill requirements for multiple products (e.g., venlafaxine XR, glycopyrrolate, calcitriol, amphetamine-dextroamphetamine ER, donepezil/memantine)
    Consequence if not metClaim routes to prior authorization
    inv-46: antifungal/oral suspension lookback — 30 days
    Lookback window30 days (clotrimazole troches, fluconazole, or nystatin oral suspension fill documented within previous 30 days)
    Applies toOravig buccal tablet routing (antifungal/oral suspension comparators)
    Consequence if not metClaim will not route online and prior authorization is required
    inv-47: high-potency opioid lookback — 120 days
    Lookback window120 days (narcotic medication fills documented within previous 120 days)
    Applies toHigh-potency extended-release opioid initiation — defines narcotic‑naive risk mitigation
    Consequence if not metPrior authorization required when pharmacy profile lacks prior narcotic fills
    inv-48: Ongentys concomitant therapy lookback — 180 days
    Lookback window180 days (concurrent use documented within previous 180 days)
    Applies toONGENTYS/entacapone routing — requires concurrent levodopa/carbidopa or entacapone exposure
    Consequence if not metClaim routes to prior authorization
    inv-49: clotrimazole/fluconazole/nystatin fill look-back — 30 days
    Lookback window30 days (clotrimazole troches, fluconazole, or nystatin oral suspension fill documented within previous 30 days)
    Applies toRouting requirement for clotrimazole/fluconazole/nystatin comparators (Oravig)
    Consequence if not metClaim will not route online and prior authorization is required
    inv-50: oxcarbazepine fill look-back — 90 days
    Lookback window90 days (oxcarbazepine fill documented within previous 90 days)
    Applies toOxcarbazepine refill routing (ER products)
    Consequence if not metPrior authorization required
    inv-51: methylphenidate ER fill look-back — 120 days
    Lookback window120 days (generic methylphenidate SR/ER fill documented within previous 120 days)
    Applies toMethylphenidate ER products to avoid prior authorization
    Consequence if not metPrior authorization required
    inv-52: ACE + ARB fill look-back for aliskiren — 180 days
    Lookback window180 days (both an ACE inhibitor AND an ARB filled within previous 180 days)
    Applies toAliskiren routing — requires documentation of ACE + ARB fills
    Consequence if not metPrior authorization required
    inv-53: ondansetron fill look-back — 180 days
    Lookback window180 days (ondansetron fill documented within previous 180 days)
    Applies toAprepitant products (e.g., Emend) and Sancuso patch routing
    Consequence if not metPrior authorization required
    inv-54: tretinoin/adapalene fill look-back — 90 days
    Lookback window90 days (tretinoin or adapalene fill documented within previous 90 days)
    Applies toTazarotene cream/gel products routing
    Consequence if not metPrior authorization required
    inv-55: immediate-release tramadol fill look-back — 90 days
    Lookback window90 days (immediate-release tramadol fill documented within previous 90 days)
    Applies toTramadol ER products routing
    Consequence if not metPrior authorization required
    inv-56: SSRI or allopurinol fill look-back — 90 days
    Lookback window90 days (generic SSRI or allopurinol fill documented within previous 90 days)
    Applies toTrintellix (SSRI comparator) and febuxostat (Uloric; allopurinol comparator)
    Consequence if not metPrior authorization required
    inv-57: prior fill lookback — 90 days
    Lookback window90 days (general prior-fill lookback used for multiple products to determine routing)
    ExamplesTrintellix, febuxostat (Uloric), zolpidem sublingual and others use a 90-day prior-fill criterion
    Consequence if not metPrior authorization required
    inv-58: concurrent-use lookback for phosphate binder — 120 days
    Lookback window120 days (concurrent phosphate binder use documented within previous 120 days)
    Applies toXphozah (tenapanor) routing — requires concurrent phosphate binder use to route online
    If not metPrescriber may request prior authorization via standard authorization process
    • Acceptable documentation: pharmacy profile, prescription claim history, or supporting medical record notes showing dates and product names
    • Operational note: if documentation is not on the profile, prescriber may request authorization using the standard prior authorization process
    Prior Authorization

    Prescriber may request authorization when profile lacks required concurrent use

    Prescribers may request prior authorization using the standard authorization process when the patient's Independent Health pharmacy profile does not document the required prior fill or concurrent use. Authorization can be approved based on submitted clinical documentation that demonstrates medical necessity or prior use of the required comparator.

    • When pharmacy history lacks required concurrent phosphate binder use for Xphozah, prescriber may submit PA request
    • Provide clinical notes, prior dispensing receipts, or other evidence to support lack of documented prior fill
    Step Therapy

    Step therapy enforced via prior-fill requirement

    Step therapy for listed products is enforced via a prior-fill requirement: the patient's pharmacy history must document a fill of the specified alternative medication within the stated lookback window before the requested product will adjudicate online. If the prior-fill criterion is not met, the claim routes to prior authorization.

    • Mechanism: online routing based on pharmacy fill history
    • If no prior fill found within lookback window → claim routes to PA
    • Prescribers may provide documentation to request PA if profile is incomplete
    Step Therapy

    Routing summary — each product requires a recent fill of specified alternative within lookback window

    Each listed product below requires documentation of a recent fill of the specified alternative (the step) within the product-specific lookback window; absence of that fill routes the claim to prior authorization.

    • TRINTELLIX TABLET 5 MG — requires generic SSRI fill within previous 90 days (routes to PA if not found)
    • ULORIC (febuxostat tablets 40 mg, 80 mg) — requires allopurinol fill within previous 90 days (routes to PA if not found)
    • XPHOZAH (tenapanor 30 mg) — requires concurrent phosphate binder use within previous 120 days (prescriber may request PA if not documented)
    • ZOLPIDEM TARTRATE SUBLINGUAL 3.5 MG — requires generic zolpidem fill within previous 90 days (routes to PA if not found)
    Step Therapy

    Trintellix step therapy rule

    TRINTELLIX: Step rule — A prescription adjudicates online only if the patient's pharmacy history documents a generic SSRI fill within the prior 90 days. If the lookback criterion is not met, the claim will route to prior authorization.

    • Comparator: generic SSRI (e.g., sertraline, fluoxetine, escitalopram)
    • Lookback window: 90 days
    • If no qualifying SSRI fill: route to PA
    Step Therapy

    Uloric step therapy rule

    ULORIC (febuxostat): Step rule — A prescription adjudicates online only if the patient's pharmacy history documents an allopurinol fill within the prior 90 days. If the lookback criterion is not met, the claim will route to prior authorization.

    • Comparator: allopurinol
    • Lookback window: 90 days
    • If no qualifying allopurinol fill: route to PA
    Step Therapy

    Xphozah step therapy rule

    XPHOZAH (tenapanor): Step rule — A prescription adjudicates online only if the patient's pharmacy history documents concurrent use of a phosphate binder within the prior 120 days. If the profile does not document concurrent phosphate binder use, the prescription will route to prior authorization; the prescriber may submit a PA with supporting clinical documentation.

    • Comparator: phosphate binder (concurrent use)
    • Lookback window: 120 days
    • If no documented phosphate binder use: prescriber may request PA using standard process
    Step Therapy

    Zolpidem sublingual step therapy rule

    Zolpidem sublingual: Step rule — A prescription adjudicates online only if the patient's pharmacy history documents a generic zolpidem fill within the prior 90 days (some entries reference 365-day windows for other sedative hypnotics; verify product-specific window). If the lookback criterion is not met, the claim will route to prior authorization.

    • Product: zolpidem tartrate sublingual 3.5 mg
    • Comparator: generic zolpidem immediate-release
    • Lookback window: 90 days (note: some Belsomra/Belsomra entries reference 365 days)
    • If no qualifying zolpidem fill: route to PA

    applies to Trintellix (vortioxetine)

    Uloric initial therapy

    Febuxostat (Uloric) prior therapy routing

    Febuxostat initial: Online routing if allopurinol fill is documented in Independent Health prescription history within the previous 90 days; otherwise prior authorization required.90 days

    applies to febuxostat (Uloric)

    Xphozah initial therapy

    Xphozah (tenapanor) concurrent therapy routing

    Xphozah initial: Online routing requires documentation of concurrent phosphate binder use within the previous 120 days; otherwise prescriber must request prior authorization via the standard authorization process.120 days

    applies to Xphozah (tenapanor)

    Zolpidem initial therapy

    Zolpidem sublingual prior therapy routing

    Zolpidem sublingual initial: Online routing if generic zolpidem fill is documented within the previous 90 days; otherwise prior authorization required.90 days

    applies to zolpidem tartrate sublingual tablets

    ConditionLookback window / requirementProvider action
    No documented concurrent use of a phosphate binder for Xphozah (tenapanor)
    Concurrent use documented within previous 120 days required
    Prior authorization required; prescriber may request authorization via the standard authorization process if profile lacks documentation
    RequirementLookback windowConsequence if not met
    Documentation of a prior fill of generic zolpidem
    90 days
    Prior authorization required if no documented generic zolpidem fill within 90 days
    Narcotic‑naive: described as a patient who has not filled narcotic medications within the prior 120 days
    ImplicationStarting listed high‑potency extended‑release opioids in a narcotic‑naive patient requires prior authorization
    Policy reasonThese high‑potency narcotics pose serious risks if started in narcotic‑naive patients